Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of β -catenin/TCF pathway

2007

Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of β -catenin/TCF pathway

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

61

References

23

Citations